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Bcl2-associated athanogene 3 (BAG3) protein is a member of BAG family of co-chaperones that interacts with the ATPase
domain of the heatshockprotein(Hsp) 70through BAG domain (110–124 amino acids). BAG3 is the only member of the familyto
be induced by stressful stimuli, mainly through the activity of heat shock factor 1 on bag3 gene promoter. In addition to the BAG
domain, BAG3 contains also a WW domain and a proline-rich (PXXP) repeat, that mediate binding to partners different from
Hsp70. These multifaceted interactions underlie BAG3 ability to modulate major biological processes, that is, apoptosis,
development, cytoskeleton organization and autophagy, thereby mediating cell adaptive responses to stressful stimuli.
In normal cells, BAG3 is constitutively present in a very few cell types, including cardiomyocytes and skeletal muscle cells, in
whichtheproteinappearstocontributetocellresistancetomechanicalstress.AgrowingbodyofevidenceindicatethatBAG3is
instead expressed in several tumor types. In different tumor contexts, BAG3 protein was reported to sustain cell survival,
resistance to therapy, and/or motility and metastatization. In some tumor types, down-modulation of BAG3 levels was shown, as
aproof-of-principle,to inhibit neoplasticcell growth inanimalmodels.This reviewattemptstooutlinethe emergingmechanisms
that can underlie some of the biological activities of the protein, focusing on implications in tumor progression.
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Bcl2-associated athanogene (BAG) proteins are a family of
co-chaperones that interact with the ATPase domain of the
heat shock protein (Hsp) 70 through a speciﬁc structural
domain known as BAG domain (110–124 amino acids).
1,2
Members of the family are found throughout the evolution in
yeast (Saccharomyces cerevisiae, Schizosaccharomyces
pombe), invertebrates (Caenorhabditis elegans, Ciona
intestinalis, Drosophila), amphibians (Xenopus laevis), mam-
mals (humans, mice) and plants (Oryza sativa, Arabidopsis
thaliana),
1,3–6 suggesting a fundamental biological role.
BAG3 was originally identiﬁed by yeast two-hybrid screen-
ing using the ATPase domain of the Hsp (heat shock cognate
(Hsc)/Hsp)70asabait.
1InadditiontotheBAGdomain,BAG3
contains a WW domain and a proline-rich repeat (PXXP;
Figure 1a) that mediate binding to other partners.
1,7,8
Here we will outline the roles so far identiﬁed of BAG3 in the
regulation of major biological processes, that is, apoptosis,
development, cytoskeleton organization and autophagy. By
modulating these pathways, BAG3 appears to mediate cell
adaptive responses to stressful stimuli, and its alterations
result in altered homeostasis and reduced cytoprotection,
explaining why its expression is often found deregulated in a
vast series of tumors.
BAG3 Protein and bag3 Gene Expression
Two BAG3 forms have been described so far: one is the
full-lenght product of the bag3 gene having an apparent mass
of 74kDa, the other one is a shorter BAG3 protein found in
association to neuronal synaptosomes
2,9–11 (Figure 1b). The
BAG3 full-length protein is localized in the cytoplasm, mainly
concentrated in the rough endoplasmic reticulum; on cell
exposure to stressors, a slightly different molecular weight
variant of this form can also be observed, and both co-exist in
some cell types and run as a doublet in a standard western
blot. The origin of this doublet is currently unknown, but it
could derive from post-translational modiﬁcations as phos-
phorylations, indeed BAG3 protein contains several serine-
richmotifsand10tyrosineresidues.Tyrosinephosphorylation
of BAG3 occurs on EGF stimulation in human breast cancer
cell lines.
12 This post-translational variant of BAG3 protein
appears also to be associated to Bruton’s tyrosine kinase
(Btk) protein in Defew cells on oxidative stress induction.
13
Recently, a shorter form of BAG3 (40kDa) has been
characterized by immunoprecipitation from neural synapto-
somes homogenates and successive mass spectrometry,
11
again it is yet unknown whether this form derives from the
alternative splicing or proteolytic processing.
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www.nature.com/cddisBAG3 expression has also been observed in the nuclei
of some cell types, including pancreatic carcinoma cells
(unpublished results from our laboratory). Interestingly,
BAG3 was shown to localize in nuclei of cells infected
by some viruses; those ﬁndings suggest an involvement of
BAG3 in viral expression and/or replication, and indeed some
reports indicate a requirement for BAG3 for virus gene
expression and/or viral progeny production.
12,14–18 In keeping
with those results, viral infection was shown to induce the
expression of BAG3, as a possible tool contributing to virus
life cycle.
12,19
In humans, bag3 gene expression is constitutive in
myocytes, a few other normal cell types and several primary
tumors or tumor cell lines (lymphoid or myeloid leukemias,
lymphomas, myeloma, neuroblastoma, pancreas, thyroid,
breast and prostate carcinomas, melanoma, osteosarcoma,
kidney, colon and ovary cancers, glioblastoma).
20–37 It is
instead induced in different normal cell types (leukocytes,
epithelial and glial cells, retinal cells) by a variety of stressors,
such asoxidants, high temperature, serum deprivation, heavy
metals, HIV-1 infection, ELF exposure, electrophile stress,
hemodialysis treatment, pulsed ultrasound, retinal light
damage, kanaic acid-induced seizure and transient forebrain
ischemia.
2,10,14,19,35,37–44
The expression of stress-responsive genes is regulated by
theheatshocktranscriptionfactors(HSFs),
45includingHSF1,
that is required for tumor initiation and maintenance in a
variety of cancer models.
46 bag3 gene promoter activity is
regulated by HSF1,
31,47,48 again suggesting a role in tumor
formation.Other knowntranscription factors thatare knownto
regulate bag3 expression are Egr1
29 AibZIP
26 and WT1.
49
The regulation by WT1 is of particular interest because of the
role played by this transcription factor in human leukemias
50
(see the section BAG3 in leukemias). Furthermore, in some
cell types bag3 expression seems to be controlled by its own
product.
51
A number of drugs – proteasome inhibitors, TNF-related
apoptosis-inducing ligand, ﬂudarabine, cytosine arabinoside
and etoposide – increase BAG3 protein levels, this in turn
contributes to cell resistance to therapy, and indeed bag3
silencing improves neoplastic cell apoptotic response to
drugs.
21,22,24,30,37,52,53
BAG3 in Development
In some cell types, bag3 expression appears to be deve-
lopmentally regulated. In the developing central nervous
system (CNS) of a rat, there is a transient expression,
detectable by immunohistochemistry, of BAG3 in the cerebral
cortex and hippocampus, whereas a considerable expression
is maintained in the rostral migratory stream and the sub-
ventricular zone of the lateral ventricle; there is an abrupt
increase of BAG3-positive neurons in the cortex and
hippocampus during the ﬁrst postnatal week, which declines
thereafter. Two speciﬁc populations of BAG3-positive
neurons can be identiﬁed in the developing forebrain of a
rat.
54 Furthermore, recent results indicated that BAG3 is
expressed in neural progenitors and sustains proliferation,
mainly in response to FGF2, in those cells.
55 In addition, an
early transient expression of BAG3 was observed in midline
radial glia in the developing brainstem and spinal cord of a
rat.
56 Together, these pieces of evidence indicate a role for
BAG3 in the development of both the neuronal and glial
components of central nervous system. In agreement with the
hypothesis of BAG3 involvement in CNS development, an
altered BAG3 expression was observed in the cerebellum of
hypothyroid juvenile mice, and was suggested to contribute to
impaired development of the hypothyroid brain. Moreover, in
rat and human cardiomyocytes, BAG3 protein appears to be
expressed during differentiation from cardiomyoblasts and to
sustain myogenin expression.
57 These ﬁndings indicate an
involvement of BAG3 protein in late heart development and
are in keeping with the role of BAG3 in the survival and
myoﬁbrillar integrity in cardiocytes and, in general, in muscle
cells. Indeed, mice with homozygous disruption of bag3 gene
develop post birth an early fulminant myopathy
23 and, in
humans, a heterozygous p.Pro209Leu mutation in BAG3
proteinwasrecentlyrecognizedtoberesponsibleforasevere
muscular dystrophy with cardiomyopathy and severe respira-
tory insufﬁciency.
57–59 In one of the three studied families
carrying this mutation, an axonal neuropathy was also
present. This observation is intriguing in view of the reported
localizationofa40kDformofBAG3insynaptosomes
11andof
the above discussed role of BAG3 in CNS. Finally, a recent
paper reports a role of BAG3 in the development of the
hematopoietic system, showing that mice with a targeted
disruption of bag3 exhibit a loss of hematopoietic stem cells
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Figure 1 (a) Human BAG family proteins. All six reported BAG proteins contain
a BAG domain at their C-terminus. Some BAG proteins contain other domains
includingnuclearlocalizationsignal(NLS),ubiquitin-like(UBL)domain,WWdomain
and proline-rich regions (PXXP). Numbers next to the linear peptide sequence
indicate amino acid number in the proteins. (b) Schematic representation of the
full-length BAG3 protein and the shorter BAG3 protein found to be associated to
synaptosomes
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Cell Death and Diseaseand defective B-cell development, because of the micro-
environmental defect, that is, an alteration in the vascular
stem cell niche.
60 The authors observed a defective growth of
stromal progenitor cells in colony-forming unit ﬁbroblasts, a
defect in sinusoidal endothelium, and the loss of stromal cells
expressing CXCL-12 or IL-7 in the bone marrow.
60 The
molecular mechanisms underlying those perturbations could,
once identiﬁed, disclose novel prospects in the understanding
of the hematopoietic process.
Last but not least, recent evidence indicate that BAG3 is
also implicated in regulating the general metabolic state of
the organism, as bag3-deﬁcient mice were reported to show
signiﬁcant hypoglycemia, a decrease in triglyceride and
cholesterol levels and growth retardation, and died by 3
weeks after birth.
61
Altogether these data show a fundamental role of BAG3 in
regulating essential physiological events.
BAG3 and Apoptosis
A number of studies in tumor cell lines of different origin
have shown that bag3 silencing or hyperexpression results
in, respectively, enhancing or inhibiting spontaneous or
drug-induced apoptosis.
9,24,25,30,31,34,36,37,44,49 Furthermore,
caspases trigger BAG3 cleavage, thereby facilitating the
apoptotic process.
52,62
BAG3 seems to inﬂuence cell survival by interacting with
different molecular partner, thus activating multiple pathways.
A ﬁrst demonstrated mechanism of BAG3 anti-apoptotic
activity is mediated by its role, as a co-chaperone, in protein
deliverytotheproteasome.Indeed,althoughanothermember
of BAG family, that is, BAG1, positively cooperates with
Hsp70 and CHIP (C-terminus of the Hsc70-interacting
protein) to direct, through its ubiquitin-like domain (Figure 1),
client proteins to proteasome,
63 BAG3 can interfere with this
process by competing with BAG1.
2,4,29,52 Indeed, in osteo-
sarcoma and melanoma cells, BAG3 protects IKK-g from
proteasome delivery and this results in sustained NF-kB
activation and cell survival.
37 A different mechanism has been
observed in glioblastoma cells, in which BAG3 retains BAX
protein in the cytosol, preventing its mitochondrial transloca-
tion.
36BothmechanismsrelyonaninteractionbetweenBAG3
and Hsp70.
36,37 We can speculate that through its binding to
Hsp70, BAG3 might also positively or negatively modulate
folding of other apoptosis-regulating proteins, and expect that
future research will disclose a very complex regulative
mechanism mediated by this protein. More over, as HSP70
can bind to AU-rich elements in the 30-untranslated regions,
regulating expression of a number of proteins, including the
well-known pro-apoptotic, BH3 only protein Bim,
64 BAG3
might be expected to regulate Hsp70 ability to stabilize Bim
mRNA and possibly other mRNAs, involved in various cell
functions.Finally, we canenvisage functionsofBAG3 thatare
independent of Hsp70, as it could also bind some client
proteins through its WW or PXXP domain, directly inﬂuencing
their stability, localization or activity (Figure 2). It is likely that
the availability of the different partners underlies the different
mechanisms through which BAG3 exerts its anti-apoptotic
activity in different cell types.
BAG3, Cytoskeleton, Cell Adhesion and Motility
It has been shown that bag3 silencing reduces adhesion and/or
motility of epithelial (breast, prostate) tumor cells.
27,32,65,66 In
MDA435 human breast cancer cells, BAG3 overexpression
resulted in a decrease in migration and adhesion to matrix
molecules; the decrease was reversed on deletion of the
BAG3 proline-rich (PXXP) domain, indicating that an inter-
action of BAG3 with a SH3 domain-containing protein was
involved.
65 Expression array studies showed that indeed
BAG3 regulated, in a PXXP-dependent manner, the expres-
sion of CCN (Cyr61, connective tissue growth, NOV) 1, a
matricellular signaling protein that promotes cell adhesion
through integrins and heparan sulfate-containing proteogly-
cans.
32 In addition, BAG3 seems to regulate cell adhesion
through binding to guanine nucleotide exchange factor 2
(PDZGEF2). This protein induces the activation of Rap1, a
regulator of cell–cell junction formation and remodeling, and
increases integrin-mediated cell adhesion. The PPDY motif at
the C-terminus of PDZGEF2 was shown to bind to the WW
domain of BAG3, and PDZGEF2 knockdown reduced BAG3
ability to induce cell adhesion in Cos7 cells.
67
Similarly to what we described above for apoptosis, the
ability of BAG3 to regulate cell adhesion appears to rely on
multiple interactions of this protein through different structural
domains. It is important to note that modulation of cell
adhesion has profound effects on cell vitality, as cell
detachment from matrix induces the apoptotic process known
as anoikis.
68 Therefore, BAG3 alterations could underlie
effects on both cell detachment/motility and resistance to
associated anoikis, thereby favouring metastatization.
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Figure 2 Mechanism of BAG3 activity on (a) client proteins, (b) client mRNAs
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Cell Death and DiseaseFinally, we recently reported that BAG3, through its
interaction with the cytosolic chaperonin CCT (chaperonin
containing TCP-1), regulates actin folding.
66 This property of
BAG3 highlights its involvement in cytoskeleton organization,
possibly inﬂuencing not only cell survival and migration, but
also membrane trafﬁcking and organellar dynamics.
BAG3 and Autophagy
The role played by BAG3 in the cytoskeleton remodeling and
membrane trafﬁcking suggests the possibility that it might be
involved in autophagy. With this term, we refer to a set of
nonspeciﬁc bulk degradation processes, in which cells deliver
cytoplasmic substrates for lysosomal degradation.
69 There is
a chaperone-mediated autophagy (CMA), selective for
cytosolic proteins that contain a pentapeptide motif: this motif
is recognized by the chaperone Hsc70, which transfers
protein substrates to lysosomes.
69 As BAG3 is a Hsc/Hsp
70 co-chaperone, it is plausible to imagine its involvement in
CMA, but we can also envisage a role in the other two types of
autophagy, namely micro- and macroautophagy. In macro-
autophagy, cells form double-membrane vesicles, called
autophagosomes, around a portion of cytoplasm; autophago-
somes are trafﬁcked along microtubules and fused with
lysosomes, resulting in degradation of their contents. Micro-
autophagy is a process in which lysosomes directly engulf
cytoplasm.
69 Similar to Hsps and BAG3, autophagy is
upregulated under stress. Indeed, the autophagic process is
important in promotingcell survivalin several conditions, such
as protein aggregate formation, nutrient and growth factor
deprivation, ER stress and pathogen infection. Defective
autophagy is associated with diverse diseases, including
neurodegeneration, lysosomal storage diseases, muscular
dystrophies, cancers and Crohn’s disease.
69
BAG3 participates, along with HspB8, a member of the
HspB family of molecular chaperones, in the degradation of
misfolded and aggregated proteins via macroautophagy.
Indeed HspB8 forms a stable complex with BAG3 in cells
and the formation of this complex is essential for the HspB8-
mediated degradation of the polyglutamine protein Htt43Q
(HunTingTin exon 1 fragment with 43 CAG repeats), a
pathogenic form of huntingtin prone to aggregation.
70,71
HspB8 and BAG3 induce, in a Hsp70-independent manner,
the phosphorylation of the a-subunit of the translation initiator
factor eIF2; this in turn causes a translational shutdown and
stimulates autophagy. The mechanism by which the BAG3/
HspB8 complex induces eIF2 phosphorylation is not com-
pletely understood.
70,71 BAG3 binding to HspB8 is mediated
by two conserved Ile–Pro–Val (IPV) motifs located between
theW-andthePro-richdomainsoftheco-chaperone;deletion
of these motifs suppresses HspB8 activity in Htt43Q
degradation.
72 Interestingly, the p.Pro209Leu mutation
responsible for dystrophy is in one of the two IPV motifs.
58,72
This suggests that the disease pathogenesis could involve
defective autophagy. Through the same protein region, BAG3
canbindalso toanotherchaperoneHspB6.Thisisparticularly
intriguing in view of the cardioprotective property of HspB6/
Hsp20
73 and its role in myocyte contractility.
74 Finally, BAG3
complexes with the ubiquitin-binding protein p62/SQSTM1,
that, by binding simultaneously the autophagosome protein
LC3 and polyUb-proteins, controls the sequestration of
polyUb-proteins into inclusion bodies for autophagic
degradation.
75
Therefore, BAG3 appears to negatively regulate protein
delivery to proteasome, by competing with BAG1, but at the
same time it stimulates autophagy. This suggests that,
although BAG1 constitutively assures, in combination with
Hsc/Hsp70, proteostasis through the ubiquitin–proteasome
system (UPS), stressful stimuli, by inducing BAG3 increase,
determine an inhibition of UPS (because of the BAG3
competition with BAG1) and a stimulation of autophagy. In
agreement with this hypothesis, BAG3/BAG1 protein ratio
increases, concomitantly with an increase in autophagy, in an
in vitro model of cell aging (replicative senescence: I90 cells)
and in rodent brain neurons during aging.
75 The authors
attribute BAG3 increase to oxidative stress due to the
enhanced pro-oxidant milieu characteristic of aging. As this
milieu enhances the occurrence of protein aggregation,
BAG3-stimulated autophagy is interpreted as an adaptive
response of the protein quality control system.
75
BAG3 in Leukemias
BAG3 is expressed at low levels in normal blood cells,
whereas it is highly expressed both in primary leukemic blasts
or established cells lines from leukemic patients.
21,22 Further-
more, its levels are markedly higher in drug-resistant patients
compared with patients that resulted responsive to chemo-
therapy. One mechanism responsible for bag3 overexpres-
sion in leukemic cells relies on the effect of the WT1
transcription factor on the bag3 gene promoter.
49 WT1 is
overexpressed in acute lymphoblastic and myeloblastic
leukemia, and high levels of the protein are associated with
a poor response to therapy.
50 We recently showed that the
WT1 isoform þKTS was able to positively regulates BAG3
expression by a transcriptional mechanism, via a direct
binding on two WT1 consensus sites on the bag3 gene
promoter. WT1 knockdown induces apoptosis, whereas its
overexpression protects leukemic cells from apoptosis
inducers; these effect are in part because of the modulation
ofBAG3proteinlevels.
49TheroleofBAG3modulationiseven
more evident in primary human leukemia cells. Indeed in
leukemic cells from 24 patients affected by B-cell chronic
lymphocyticleukemia(B-CLL)
21andfrom 11childrenaffected
by acute lymphoblastic leukemia,
22 we observed that BAG3
down-modulation by speciﬁc antisense oligodeoxynucleo-
tides results in enhancing the percentage of apoptotic
elements by 4100%. Cell apoptosis was enhanced in cells
either untreated or incubated with chemotherapeutic drugs.
Those were the ﬁrst reported evidence of the apoptosis-
regulating activity of BAG3 protein in primary tumors.
21,22
We also showed that BAG3 down-modulation increased
apoptosis of primary normal human peripheral blood mono-
nuclear cells as well as of leukemic cells incubated with
agents able to induced oxidative stress.
39 Furthermore, a
physical interaction was observed between BAG3 and the
Btk under oxidative stress conditions. All those evidences
assign to BAG3 a critical role in the leukemic cell survival
and responsiveness to chemotherapy and should prompt
Multifaceted BAG3
A Rosati et al
4
Cell Death and Diseaseinvestigators to further investigate its role in these deseases
and the possibility of exploiting it as a molecular target.
Conclusions
From the ﬁrst evidence of BAG3-mediated survival in
B-CLLs,
21 a number of reports conﬁrmed the anti-apoptotic
activity of the protein in tumors of the hemato-
poietic
2,13,21,22,25,28,30,39,40,49 and other
2,20,24,25,29,31,34,36,37,44
compartments. Two principal elements contribute to the role
of BAG3 in vast range of tumors: bag3 induction by HSF1,
47 a
transcription factor activated in many cancer types;
46 and
BAG3 ability to sustain of NF-kB activity.
76 In addition, BAG3,
because of its multifaceted ability to complex with many
proteins, can regulate factors that are particularly relevant in
the context of speciﬁc tumor types, such as BAX in
glioblastoma cells.
36
Overall, studies on BAG3 expression and activity in normal
and neoplastic cells, and of its regulation during the develop-
ment, increasingly delineate a complex picture of BAG3
involvement in physiological and pathological processes. The
pleiotropic functions attributed to BAG3 probably reﬂect the
adapter nature of this multidomain (BAG, WW and PXXP)
protein and its ability to assemble scaffolding complexes,
which participate in more than one signal transduction
pathway.
It is of particular interest that BAG3 deﬁciency can result in
the loss of hematopoietic stem cells due to a defect in stem
cell niche.
61 Therefore, BAG3 is required for the stem cell-
supporting activity of microenvironmental cells. This ﬁnding
suggests that BAG3 may also regulate the cancer stem
cell-supporting activity of stromal cells in the hematopoietic
and possibly in other compartments. Again, NF-kB factors
could represent key targets of BAG3, not only for the
expression of tumor cell genes that sustain cell survival, but
also for the expression of stromal cells’ soluble and cell
surface molecules that mediate bidirectional interactions
between tumor cells and their environment.
77,78
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